BRTX Stock Analysis: Buy, Sell, or Hold?
BRTX - BioRestorative Therapies, Inc. Common Stock (NV)
$0.34
-0.02 (-4.23%)
▼
5d:
-21.6%
30d:
+40.25%
90d:
+56.12%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 20, 2026
0d
Get Alerted When BRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called BRTX this week
86% bullish • 1 bearish
86% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BRTX is down 21.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BRTX is down 21.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BRTX is currently trading at $0.34, which is considered slightly high relative to its 30-day fair value range of $0.17 to $0.35.
Technical Outlook: Technically, BRTX is in a strong downtrend. Immediate support is located at $0.16, while resistance sits at $0.68. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: BRTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+2257.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BRTX is in a strong downtrend. Immediate support is located at $0.16, while resistance sits at $0.68. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: BRTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+2257.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.17 -
$0.35
Company Quality Score
58/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
68.4%
All Signals
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-4.2%)
- BULLISH: Trading 2257.1% below Wall St target ($8.00)
- WARNING: Recommendation downgraded due to -21.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.17 -
$0.35
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.16
Resistance Level
$0.68
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.65
Wall Street Target
$8.00
(+2257.1%)
Revenue Growth (YoY)
-54.7%
Share & Embed Analysis
Last updated: June 03, 2026 6:17 PM ET
Data refreshes hourly during market hours. Next update: 7:17 PM
Data refreshes hourly during market hours. Next update: 7:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 52 HOLD |
